-
-
-
-
-
-
-
iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
iBio to Report Fiscal 2022 Third Quarter Financial Results and Provide Corporate Update on Thursday, May 12, 2022
-
-
-
-
-
-
-
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
iBio to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Update on Monday, November 16 ,2020
-
-
-
-
-
-
-
iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar
-
-
-
-
-
-
-
iBio, Inc. (IBIO) Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize Possible Reverse Stock Split
-
-
-
-
-
-
-
iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance
-
1,224,036 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

